San Salvatore Academic Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT02728310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Anesthesia and Intensive care Unit, San Salvatore Academic Hospital | San Salvatore Academic Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

levobupivacaine (chirocaine) (3 trials)

sodium chloride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2